- Home
- CNDT vs ETON Comparison
CNDT vs ETON Comparison
Compare CNDT & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNDT
- ETON
- Stock Information
- Founded
- CNDT 2016
- ETON 2017
- Country
- CNDT United States
- ETON United States
- Employees
- CNDT N/A
- ETON N/A
- Industry
- CNDT Business Services
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- CNDT Consumer Discretionary
- ETON Health Care
- Exchange
- CNDT Nasdaq
- ETON Nasdaq
- Market Cap
- CNDT 448.6M
- ETON 498.8M
- IPO Year
- CNDT N/A
- ETON 2018
- Fundamental
- Price
- CNDT $2.38
- ETON $18.01
- Analyst Decision
- CNDT
- ETON Strong Buy
- Analyst Count
- CNDT 0
- ETON 3
- Target Price
- CNDT N/A
- ETON $29.67
- AVG Volume (30 Days)
- CNDT 1.1M
- ETON 244.5K
- Earning Date
- CNDT 11-07-2025
- ETON 11-06-2025
- Dividend Yield
- CNDT N/A
- ETON N/A
- EPS Growth
- CNDT N/A
- ETON N/A
- EPS
- CNDT 0.06
- ETON N/A
- Revenue
- CNDT $3,112,000,000.00
- ETON $58,181,000.00
- Revenue This Year
- CNDT N/A
- ETON $105.25
- Revenue Next Year
- CNDT $4.32
- ETON $40.84
- P/E Ratio
- CNDT $38.71
- ETON N/A
- Revenue Growth
- CNDT N/A
- ETON 85.40
- 52 Week Low
- CNDT $1.90
- ETON $8.24
- 52 Week High
- CNDT $4.90
- ETON $23.00
- Technical
- Relative Strength Index (RSI)
- CNDT 36.54
- ETON 42.17
- Support Level
- CNDT $2.38
- ETON $18.00
- Resistance Level
- CNDT $2.66
- ETON $18.92
- Average True Range (ATR)
- CNDT 0.09
- ETON 0.83
- MACD
- CNDT -0.01
- ETON -0.14
- Stochastic Oscillator
- CNDT 20.00
- ETON 26.52
About CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.